# Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients

> **NCT02703298** · PHASE1 · COMPLETED · sponsor: **TaiRx, Inc.** · enrollment: 19 (actual)

## Conditions studied

- Carcinoma
- Advanced Cancer

## Interventions

- **DRUG:** TRX-818 capsules

## Key facts

- **NCT ID:** NCT02703298
- **Lead sponsor:** TaiRx, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-25
- **Primary completion:** 2018-01-23
- **Final completion:** 2018-05-03
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02703298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02703298, "Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02703298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*